SiRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses.
Ontology highlight
ABSTRACT: The ongoing pandemic of global concern has killed about three million humans and affected around 151 million people worldwide, as of April 30, 2021. Although recently approved vaccines for COVID-19 are engendering hope, finding new ways to cure the viral pandemic is still a quest for researchers worldwide. Major pandemics in history have been of viral origin, such as SARS, MERS, H1NI, Spanish flu, and so on. A larger emphasis has been on discovering potential vaccines, novel antiviral drugs, and agents that can mitigate the viral infection symptoms; however, a relatively new area, RNA interference (RNAi), has proven effective as an antiviral agent. The RNAi phenomenon has been largely exploited to cure cancer, neurodegenerative diseases, and some rare diseases. The U.S. Food and Drug Admin
SUBMITTER: Sajid MI
PROVIDER: S-EPMC9896947 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA